Oxford Biomedica annual gross profit
2020
2021
2022
2023
2024
2025
Oxford Biomedica Gross Profit Growth & History (OXB)
Oxford Biomedica's gross profit was £66.0M for fiscal 2025.
View full Oxford Biomedica company overviewOxford Biomedica annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £66.0M | £13.0M | +24.44% |
| 2024 | 2024-12-31 | £53.0M | £13.3M | +33.46% |
| 2023 | 2023-12-31 | £39.7M | −£29.5M | −42.58% |
| 2022 | 2022-12-31 | £69.2M | −£13.5M | −16.29% |
| 2021 | 2021-12-31 | £82.6M | £36.6M | +79.37% |
| 2020 | 2020-12-31 | £46.1M | — | — |
Oxford Biomedica gross profit trends
Over the last five fiscal years, Oxford Biomedica's gross profit increased from £46.1M to £66.0M, a change of £19.9M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
reported and calculated gross profit
TickerStat uses gross profit reported in company official filings when available. Otherwise, it calculates gross profit as reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oxford Biomedica source filings ↗